APA

Quarcoo D., Weixler S., Joachim R. A., Stock P., Kallinich T., Ahrens B. & Hamelmann E. (20041220). Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in mice. : Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Chicago

Quarcoo D, Weixler S, Joachim R A, Stock P, Kallinich T, Ahrens B and Hamelmann E. 20041220. Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in mice. : Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Harvard

Quarcoo D., Weixler S., Joachim R. A., Stock P., Kallinich T., Ahrens B. and Hamelmann E. (20041220). Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in mice. : Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

MLA

Quarcoo D, Weixler S, Joachim R A, Stock P, Kallinich T, Ahrens B and Hamelmann E. Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in mice. : Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 20041220.